| Author, year, Location | Sample description | No. Eligible | Measurement Period | Rate (%)/ Key Differences |
|---|---|---|---|---|
| Appropriate use of definitive locoregional therapy (total mastectomy + axillary lymph node dissection, or, breast-conserving surgery + axillary lymph node dissection + radiotherapy) IV | ||||
| Nattinger, 2000, US | National population-based sample women ≥30 y at the time of first diagnosis of invasive local or regional unilateral BC | 144,759 | 1995 | 78%/NA |
| Hebert-Croteau, 1999, Canada | Random sample newly diagnosed stage I–II BC women ≥50 y treated in Quebec | 1,174 | 1993-1994 | NR/Age: 50–69 y: 83.5%; ≥70 y: 48.7% |
| Silliman, 1999, US | Convenience sample women ≥55 y newly diagnosed stage I or II BC treated 1 center in Boston | 303 | NR | 77.2% (Surgery type: BCS + RT: 56%; Mastectomy: 22%)/ Income: ≤U$14,999: 55%; 15,000–29, 999: 85%; 30,000–49,999: 91%; ≥50,000: 87%/Education: < high school: 55%; high school: 75%; some college: 83%; college: 82% |
| Appropriate use of alternative definitive therapy (radiotherapy after breast-conserving surgery + axillary lymph node dissection or adjuvant treatment) IV | ||||
| Hebert-Croteau, 1999, Canada | Random sample newly diagnosed stage I–II BC women ≥50 y treated in Quebec | 1,174 | 1993-1994 | NR/Age: 50–69 y: 90.9%; ≥70 y: 60.9% |
| Silliman, 1999, US | Convenience sample women ≥55 y newly diagnosed stage I or II BC treated 1 center in Boston | 303 | NR | 51.8%/Age: 55–64 y: 50%; 65–74 y: 41%; 75–84 y: 9% |
| Cases not receiving recommended treatment (radiotherapy after breast-conserving surgery or systemic therapy) due to system failure IV | ||||
| Bickell, 2003, US | Convenience sample women ESBC who had treatment underuse; not RT or adjuvant therapy recommended when indicated | 44 | 1998-1999 | 32%/NA |
| Appropriate use: Women with metastatic cancer should be offered hormonal therapy, chemotherapy, and/or enrollment in a clinical trial with documentation of informed consent, within 6 weeks of the identification of metastases IV | ||||
| McGlynn, 2003, US | Random sample of women living in 12 US metropolitan areas | 4 | 1998-2000 | 82.6%/NA |
From: Summary Tables
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.